for what purpose?, page-3

I don't see why a large Pharma - if interested in this tech - would partner with FTT. If, as I suspect, the results are very good, they would just buy the whole bloody lot, but to do that they need to make an offer somewhere north of (insert ur own $ here) a share to get holders interested. If the SP stays put it would make FTT a very cheap acquisition. The top 20 own about 56% of the shares so it wouldn't be a street to get 75% and do as they please.